|Day Low/High||4.55 / 4.94|
|52 Wk Low/High||1.76 / 6.12|
Only one fund category (of 20) has beaten the S&P 500 over half a decade.
Intel's agreement to buy Altera highlighted a volatile session.
Though data suggest a softer eurozone recovery than expected, EverBank's Frank Trotter says it's unlikely the ECB will cut rates.
Dan Fitzpatrick, founder of StockMarketMentor.com, details three stocks he saw on TV and how to trade them.
Shares of biotech player ImmunoGen had a tremendous first quarter, CEO Daniel Junius, gives Gregg Greenberg his outlook for the rest of the year.
Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Apple, Immunogen, and Enbridge.
Portfolio manager David Peltier discusses how to play one the most volatile low-dollar stocks of 2012.
Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Immunogen, Ariad Pharma, and AutoNation.